The Impact of the Opioid Crisis on Firm Value and Investment
The Review of Financial Studies · 01.05.2025 · 38 (5) · 1291-1332
DOI: 10.1093/rfs/hhae080 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Review of Financial Studies, online erschienen am 14.02.2025. Verfasst von Paige Ouimet und 2 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
We show a negative effect of opioid prescriptions on subsequent individual employment among employers in our sample using doctor-opioid-prescribing propensity as our instrument. This finding has implications for firms that must now contend with lower local labor supply. We find a negative relationship between opioid prescriptions and subsequent establishment growth. However, firms respond to labor shortages by investing more in technology, replacing the relatively scarcer labor with capital, especially when they are not financially constrained. We find positive abnormal returns, upon the passage of state laws intended to limit opioid prescriptions, that are driven by firms more reliant on labor.
Zitieren
APA
Ouimet, P., Simintzi, E., & Ye, K. (2025). The Impact of the Opioid Crisis on Firm Value and Investment. The Review of Financial Studies, 38(5), 1291-1332. https://doi.org/10.1093/rfs/hhae080
Vancouver
Ouimet P, Simintzi E, Ye K. The Impact of the Opioid Crisis on Firm Value and Investment. The Review of Financial Studies. 2025;38(5):1291-1332. doi:10.1093/rfs/hhae080
BibTeX
@article{Ouimet2025,
author = {Ouimet, Paige and Simintzi, Elena and Ye, Kailei},
title = {The Impact of the Opioid Crisis on Firm Value and Investment},
journal = {The Review of Financial Studies},
year = {2025},
volume = {38},
number = {5},
pages = {1291--1332},
doi = {10.1093/rfs/hhae080}
}
EUVIMED